Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹65.3 Cr -11.3% 0.9% -42.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,750.4 Cr -2.5% -3.1% 0.3% Stock Analytics
KIRI INDUSTRIES ₹2,609.2 Cr -1% -2.7% -18.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,523.3 Cr 0.5% -0.9% -32.4% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹996.5 Cr -0.7% -3.4% -7.7% Stock Analytics
BODAL CHEMICALS ₹585.3 Cr -0.8% -2.1% -21.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-11.3%

0.9%

-42.5%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses